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Abstract
Glutathione is ubiquitous in eucaryotic cells and is implicated in many cellular functions. Release of reduced and oxidized
glutathione (GSH and GSSG) into the plasma and the ratio of GSH/GSSG are considered a reliable index to evaluate the status of
oxidative stress in biological systems. As storage temperatures and time periods have not been studied and discussed, we evaluated
the effects of storage period and temperatures on the stability of GSH in blood samples by an automated capillary electropherograph
system. After two-way ANOVA analysis, the result indicated that there were statistical significance between the GSH status and the
storage period, and the GSH status and the preserved temperature as well. However, there was no statistical significance between
samples with EDTA or with EDTA-NaF added as anticoagulant. Furthermore, no matter which freezing temperature (-20°C or -80°C)
was used for storing the samples, the concentration of total GSH was quite consistent over the course of the study. We suggest that
the alteration of the GSH status at room temperature should be due to not only the autoxidation of GSH but also the enzyme-catalyzed
degradation of GSH and GSSG.
Key words: glutathione, blood, stability, autoxidation

Introduction
Glutathione (γ-L-glutamyl-L-cysteinyl-glycine, GSH) is
a tripeptide that plays an important role in the detoxification
processes of electrophilic metabolites of xenobiotics and
oxygen free radicals. Release of reduced and oxidized
glutathione (GSH and GSSG) into the plasma is considered
to be a reliable index of oxidative stress. Alterations of the
glutathione status have been found in a variety of diseases,
including diabetes mellitus(1), human immunodeficiency
virus (HIV) infection(2), cystic fibrosis(3), acute respiratory
distress syndrome(4), chronic renal failure(5), sepsis(6), and
liver disease(7). GSH is also important for the maintenance
of α-tocopherol and ascorbic acid in the reduced state.
Therefore, the ratio of GSH/GSSG is used to evaluate the
status of oxidative stress in biological systems.
GSH not only protects cell membranes from oxidative
damage but also helps maintain the sulphydryl groups
of many proteins in the reduced form. Irreversible cell
damage supervenes when the cell is no longer able to
maintain its GSH content(8). Therefore, the measurements
of various forms of GSH concentrations in biological
samples are important for the understanding of GSH
homeostasis in clinic applications.
A variety of analytical methods have been described for
* Author for correspondence. Fax: +886-7-3121101 ext 7262;
Fax: +886-7-2370544; E-mail: tsliyu@kmu.edu.tw

the determination of GSH and GSSG in the blood and other
biologic samples, including enzymatic(9), spectrophotometric
and spectrofluorimetric (10) , high performance liquid
chromatography(11) with electrochemical detectors(12) and
by capillary electrophoresis (13,14) methods although no
reference method has yet been defined(15); nonetheless, few
of these could detect both GSH and GSSG simultaneously.
The separation of GSH and GSSG by capillary zone
electrophoresis (CZE) with direct ultraviolet detection
(200 nm filter) in whole blood, red blood cells, tissue,
mitochondria(15-18), and by micellar electrokinetic capillary
electrophoresis (MEKC) in plasma has also been reported(19).
The temperature of -80°C is suggested for preserving
and storing glutathione in biological samples (20) . But
different storage temperatures and time periods for CZE
method have not been studied and discussed. To evaluate
the effects of storage periods and temperatures on the
stability of GSH and GSSG in blood, we adopted the
washed red blood cells (RBC) from the blood with EDTA
or EDTA-NaF as anticoagulants.

Materials and Methods
I. Reagents and Calibrators
All chemicals were of an analytical grade and
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solutions were prepared with water from the Millipore
RiOs System. Boric acid, Metaphosphoric Acid (MPA),
GSH, and GSSG were obtained from Sigma Chemical
(St. Louis, MO, USA). Stock solutions containing 1
mM of GSH and GSSG were prepared in 1% (w/v)
MPA, aliquoted, and stored at -80°C. Working standard
solutions of GSH and GSSG were prepared by diluting the
stock solutions appropriately with 1% (w/v) MPA (seven
concentrations including 100 μM, 50 μM, 25 μM, 12.5 μM,
6.25 μM, 3.12 μM, and 1.56 μM). The linearity was up
to 100 μM GSH and GSSG, because there was a dilution
of 20× in the b1ood sample, the concentration equivalent
to 2000 μM. Calibration curves were constructed by liner
regression of the corrected peak area of GSH and GSSG (R
> 0.999).
II. Within-run, Between-run and Recovery Study
The within- (n =10) and between-run (n = 10) assay
for GSH and GSSG were studied at higher concentrations
(1000 μM for GSH and 100  μ M  f or GSSG) and lower
concentrations (500 μM for GSH and 50 μM for GSSG).
Recoveries of GSH and GSSG from spiked calibrators and
washed RBC (n = 5) were also studied.
III. Blood Sample Preparation and Storage
Venous blood samples (~10 mL) from 2 healthy and
nonfasting adult volunteers were collected in EDTA and
EDTA-NaF anticoagulated tubes and immediately placed
on ice. To minimize the autoxidation of thiols or the
enzymatic reduction of the disulfides, the processing of
the sample was carried out at 4°C. Red blood cells were
separated from plasma by centrifugation (3,000 rpm for 5
min) followed by three times washing with 0.9% w/v NaCl.
Red blood cells 100μl aliquots of washed RBC were added
to 300 μL of ice-cold 5% MPA. To precipitate proteins
completely, the samples were vortexed and incubated on
ice for 10 min. The acidic suspensions were centrifuged
at 12,000 rpm for 10 min at 4°C; the supernatants were
then filtered through a 0.2-μm filter, divided into parts and
stored at three different temperatures [room temperature
(RT), -20°C, and -80°C]. For each condition, triplicate
measurements for each sample were made on each of the
following days: 0, 1st, 2nd, 7th, 14th, 21st, and 28th. A
20 μL aliquot was diluted with 80 μL of deionized water
before injection (final dilution, 1:20).
IV. Instrument and Method of the Capillary Electrophoresis
System
All experiments were carried out using an automated
capillary electropherograph P/ACE-MDQ system equipped
with a fixed wavelength UV detector with an interference
filter at 200 nm (Beckman Coulter, Fullerton, CA, USA).
Throughout all the experiments, uncoated fused-silica
capillaries (75 μm I.D., 50 cm effective length) were used.

Injection of the sample was by the application of 0.5-psi
pressure for 15 sec. The capillary was thermostated at
28°C. Before each analytical run, the capillary was rinsed
and filled with the running buffer [300 mM boric acid
(pH 7.8)] for 2 min at 25 psi. The electrophoresis was
performed with a constant voltage of 25 kV (~62 μA) for
8 min. Between analytical runs, the capillary was rinsed
with 0.1 N NaOH and deionized water at 25 psi for 2
min in each. The Beckman P/ACE System 32 KaratTM
software was used for the instrument control; data were
quantified on the basis of corrected peak areas with
migration times.
V. Statistical Analysis
Tw o - w a y A N O VA w i t h o n e f a c t o r r e p e a t e d measurement was used in this study.

Results
The imprecision study for the analysis of GSH and
GSSG by CZE was evaluated in this study. The withinrun CVs for GSH and GSSG were 0.9% and 0.8%, and
3.8% and 4.2% respectively at the study concentrations.
The between-run CVs for both GSH and GSSG were less
than 10% (Table 1). The percentage of recovery in studies,
spiked with GSH and GSSG into calibrators and washed
RBC samples respectively, are depicted in Table 1.
Table 2 summarizes the percent change (gain or
loss) of GSH, GSSG, total GSH (expressed as equivalent
GSH + 2GSSG) and the ratio of GSH/GSSG in washed
RBC from the blood with EDTA or EDTA-NaF added as
anticoagulant. Moreover, the GSH, GSSG, and the total
GSH concentrations (at day 0) were respectively adopted
to be the mean baseline concentrations. Concentration of
GSH and GSSG was determined with the washed RBC
in triplicate, and total GSH and the ratio of GSH/GSSG
were calculated. The mean values from the blood with
EDTA added as anticoagulant were 1703.5 ± 74.0 μM for
GSH, 46.5 ± 4.1 μM for GSSG, 1796.7 ± 67.7 μM for
total GSH, and 36.6 ± 4.6 for the GSH/GSSG ratio; the
mean values from the blood with EDTA-NaF added as
anticoagulant were 1787.5 ± 67.4 μM for GSH, 62.0 ± 5.2
μM for GSSG, 1911.2 ± 77.5 μM for total GSH, and 28.7 ±
1.4 for the GSH/GSSG ratio. The statistical analysis (twoway ANOVA), indicated there were significant differences
with storage period and in the preserved temperature (p <
0.001). However, there was no statistical significance for
the percent change of GSH, GSSG, and total GSH between
the use of anticoagulants EDTA or EDTA-NaF.

Discussion
Measurement of blood GSH statuses (GSH & GSSG)
can be used as a marker for the change of oxidative status
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species(21). Analysis of GSH and GSSG with one single
run requires a simple, quick, sensitive, and reproducible
analytic method such as CZE. In this study, we used a CZE

in various pathological conditions. The GSH/GSSG
ratio provides a physiologic indicator of the activity of
intracellar defense system against the reactive oxygen

Table 1. Recovery of GSH and GSSG from the spiked (A) calibrator and (B) washed RBC sample (n = 5) & imprecision tests of reduced and
oxidized glutathione in calibrators*
Recovery

(A)

Calibrator added
(μM)

Measured concentration
(μM ± S.D.)

Recovery
(%)

0
100

498.6 ± 6.8
597.5 ± 7.2

—
98.9

GSH
GSSG

(B)

0

53.5 ± 3.2

—

10

63.9 ± 3.4

104.1

0

1305.2 ± 75.8

—

200

1488.8 ± 80.5

91.8

GSH
GSSG

0

87.5 ± 25.6

—

20

109.2 ± 26.3

108.5

Imprecision
Within-run variation
(n = 10)
Mean
(μM)

Between-run variation
(n = 10)

S.D.
(μM)

%CV

Mean
(μM)

S.D.
(μM)

%CV

GSH (μM)
500

495.6

4.3

0.9

492.6

7.2

1.3

1000

998.9

10.6.1

0.8

991.8

5.5

0.6

47.2
103.1

2.5
3.8

3.8
4.2

47.6
97.2

2.9
4.7

5.0
5.5

GSSG (μM)
50
100

*CV, coefficient of variation; S.D., standard deviation; GSH, reduced glutathione; GSSG, oxidized glutathione.
Table 2. The percentage changes (gain or loss) of reduced glutathione, oxidized glutathione, total glutathione, and the GSH/GSSG ratio in the
washed RBC of the two kinds of anticoagulants
GSH (% change)
Temperatures
R.T.
		
		
		
		
		
		
-20°C
		
		
		
		
		
		
-80°C
		
		
		
		
		
		

Days

EDTA

EDTA-NaF

GSSG (% change)
EDTA

EDTA-NaF

Total GSH (% change)
EDTA

EDTA-NaF

GSH/GSSG (% change)
EDTA

EDTA-NaF

0

0

0

0

0

0

0

0

0

1
2
7
14
21
28
0
1
2
7
14
21
28
0
1
2
7
14
21
28

-9.8
-14.1
-38.0
-51.5
-61.5
-73.1
0
-7.1
-3.9
-5.3
-15.6
-16.5
-19.7
0
3.4
1.6
0.3
-0.4
1.4
3.5

-4.4
-14.4
-39.3
-56.0
-64.3
-77.7
0
-7.5
-3.2
-5.2
-15.7
-15.7
-10.5
0
-2.5
-1.9
-1.2
-2.4
-1.5
-2.8

97.1
139.1
176.5
191.3
219.1
214.0
0
62.2
111.4
232.3
266.8
335.6
416.8
0
9.3
-0.9
3.4
8.1
8.4
7.9

91.0
125.9
168.9
194.2
217.1
203.6
0
36.1
74.5
135.0
176.2
225.6
253.7
0
7.8
1.3
2.3
5.5
4.0
1.8

-4.2
-6.2
-26.9
-38.9
-47.0
-58.2
0
-3.5
2.1
7.0
-1.0
1.7
2.9
0
3.7
1.4
0.5
0.0
1.8
3.8

1.9
-5.2
-25.8
-39.7
-46.0
-59.4
0
-4.6
1.9
4.0
-3.2
0.0
6.7
0
-1.8
-1.7
-0.9
-1.9
-1.1
-2.5

-54.2
-64.1
-77.6
-83.3
-87.9
-91.4
0
-42.7
-54.6
-71.5
-77.0
-80.8
-84.5
0
-5.4
2.5
-3.0
-7.9
-6.5
-4.1

-49.9
-62.1
-77.4
-85.1
-88.7
-92.7
0
-32.0
-44.5
-59.6
-69.5
-74.1
-74.7
0
-9.6
-3.2
-3.4
-7.5
-5.2
-4.6
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1

2
7
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Duration (days)

21
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-0.02
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200
150
100
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GSSG -80°C

7
14
Duration (days)
GSSG -20°C

21

28
GSSG RT

5.0

5.5

6.0

7.0

6.5

Figure 1. Electropheropherograms of GSH and GSSG in washed
RBC ( ) and whole blood (─) sample deproteinized with 5% (w/v)
MPA. A broad and unknown peak was just in front of the GSH peak
that interfered with the identification of GSH when we used whole
blood as the sample in the same CZE system condition.

─

2000
1800
1600
1400
1200
1000
800
600
400
200
0

(C)

0

GSH RT

GSH -20°C

2

4.5

Migration time (min)

1

2

GSH -80°C
250

1

Unknown peak
↓

-0.01

28

300 (B)

0

GSSG 5.8

AU

GSSG levels (uM)

GSSG levels (uM)

0.03

(A)

GSH -80°C

0

of GSSG in blood samples with EDTA-NaF added as an
anticoagulant seemed to be more stable than those with
EDTA added as an anticoagulant (1.8% gain vs. 7.9%
gain), especially in the prevention of GSSG formation
although there was no statistical significance. However,
when the samples were stored at -20°C, the GSH status
changed obviously in both groups with either anticoagulant
added from the 2nd day. In other words, the concentration
of GSSG gradually increased indicating the GSH in
the assay samples stored at -20°C is not stable. In this
condition (-20°C), the GSH/GSSG ratio decreased
gradually which would influence the validation of the

GSH levels (uM)

GSH levels (uM)

method modified by Serru et al.(15) and Ciriaco et al.(16).
In Serru’s study, the CZE was performed with a buffer
containing boric acid 75 mM and Bis-Tris 25 mM at pH 8.4.
We found the peak of GSH was decreased gradually in the
within-run assay but not so for the GSSG peak which was
not increased or decreased in concentration. The confusing
problem has been solved after we changed the buffer of
the Ciriaco’s formula (300 mM boric acid, pH 7.8). To
make the CZE results more stable and correct, rapid
acidification of the sample is critical because it prevents
both autoxidation and enzyme-catalyzed degradation via
the γ-glutamyl transfersae reaction with GSH and GSSG.
We chose Meta-phosphoric acid (MPA) to deproteinize
the whole blood and the washed RBC samples, which was
described as one of the most reliable agents for glutathione
storage(20,22).
EDTA was added as an anticoagulant according to
Serru’s method(15). Another anticoagulant, EDTA-NaF,
was also used due to the fact that it could inhibit enolase
during glycolysis presumably by reducing the activity of
glutathione peroxidase (GPx). Our data indicated that
samples with EDTA-NaF added seemed to be more stable
than those with EDTA (Figure 2).
The GSH electrophoregram pattern of samples from
the whole blood and the washed RBC were depicted in
Figure 1. As the sample from whole blood was assayed,
a broad and unknown peak appeared in front of the GSH
peak, which led to the interference of the identification
of GSH. The same phenomenon was also reported by
Serru(15). We thus chose the washed RBC samples for the
determination of GSH status.
After the 28-day storage at -80°C, the concentration

7
Duration (days)

14

21

28
GSH RT

GSH -20°C

(D)

200
150
100
50
0

0

1
GSSG -80°C

2

7
Duration (days)

14

GSSG -20°C

21

28
GSSG RT

Figure 2. Changes of GSH status in EDTA-blood (A, B) and in EDTA-NaF blood (C, D) at three different temperatures (Room temperature,
-20°C, and -80°C) for 7 different periods of time.
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Table 3. The reference values of the whole blood samples and the
washed RBC samples for GSH statuses of our laboratory.
Washed RBC
(n* = 137)

Whole blood
(n = 57)

GSH (μM)
GSSG (μM)

1294.5 ± 258.2**
81.7 ± 45.7

873.4 ± 164.3
58.2 ± 24.9

Total GSH (μM)
GSH/GSSG

1457.8 ± 277.5
20.3 ± 10.2

989.4 ± 170.6
17.7 ± 7.9

*n: sample number.
**Values are presented as mean ± S.D.

GSH status results, indicating that storage of GSH samples
at this condition is not suitable. Interestingly, no matter
which freezing temperature (-20°C or -80°C) we chose for
storing the samples, the concentration of the total GSH was
quite stable with either of these two anticoagulants over
the course of the study. We suggest that alteration of GSH
and GSSG concentrations at -20°C should be due to the
autoxidation of the GSH.
In comparison to samples with EDTA added and
stored at -20°C for 7 days and samples with EDTA-NaF
and stored at -20°C for 21 days, the GSSG concentration
o b v i o u s l y d e c r e a s e d w h e n s t o r e d a t RT a n d t h e
percentage change of total GSH concentration decreased
approximately 26% from the 7th day of the study. We
suggest that alteration of GSH, GSSG, and total GSH
concentrations over the course of the study at RT should
be due to not only the autoxidation of the GSH but also the
enzyme-catalyzed degradation of GSH and GSSG.
The reference values for GSH status of our laboratory
were shown in Table 3. The mean values of the washed
RBC samples from 137 volunteers, including 65 males and
72 females and average 51.5 years in age (from 10 to 76
years), were 1294.5 ± 258.2 μM for GSH, 81.7 ± 45.7 μM
for GSSG, 1457.8 ± 277.5 μM for total GSH, and 20.3 ±
10.2 for the GSH/GSSG ratio, respectively. The reference
values of the whole blood samples from 57 volunteers,
including 27 males and 30 females and average 52.2 years
in age (from 26 to 76 years), were 873.4 ± 164.3 μM
for GSH, 58.2 ± 24.9 μM for GSSG, 989.4 ± 170.6 μM
for total GSH, and 17.7 ± 7.9 for the GSH/GSSG ratio,
respectively.
The reference values for total, free and reduced
glutathione in plasma and in whole blood differ somewhat
from one laboratory to another. The variability may be
related to different methodology, difference in sample
processing and/or storage or the selection of subjects
who are under the influence of various factors affecting
the plasma/blood glutathione concentration. Whole
blood, washed RBC, and plasma samples were chosen for
glutathione status determination in different laboratories
for various clinical purposes. RBC contains approximately
500 times higher GSH concentration than plasma;
therefore, minor hemolysis (0.1% to 1%) can result in
erroneously high plasma values (23). Alternatively, GSH
can be lost by autoxidation which occurs with a half-time

of about 5 min in plasma at room temperature(24). Human
plasma also contains γ-glutamyltranspeptidase, an enzyme
that degrades GSH(25) and can be present at high activities
in human plasma in association with liver disease.
Griffith’s study (26) showed the stability of total
glutathione in the acidic, protein-free supernatants to be
fair at 0°C or -20°C (5 to 20 % loss per 24 hr) and good
at -78°C to -190°C (0 to 5% loss even with long-term
storage). In this study, we showed the different result in
total GSH stored at -20°C. RT is the prefer temperature in
clinical sample collection, but the GSH statuses at RT was
very unstable. Therefore, the freezing temperature is still
in need to maintain GSH statuses. In summary, the data
from the present study showed that (1) GSH and GSSG
are more stable at -80°C than those at RT or -20°C, and
(2) GSH stored at -80°C possesses good and prolonged
stability for at least one month.
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